Preview

Рецепт

Расширенный поиск

Одуванчик лекарственный. Часть 2. Фармакологические свойства

Полный текст:

Аннотация

Одуванчик лекарственный оказывает диуретическое, гипогликемическое, иммуномодулирующее, противовоспалительное, гепатопротекторное и желчегонное действие, установленное в доклинических исследованиях. В клинических исследованиях подтверждены только его диуретические свойства. В опытах на животных доказан низкий уровень токсичности корней данного растения. Одуванчик лекарственный в традиционной и научной медицине применяют при расстройствах пищеварения (тяжесть в животе, метеоризм, для усиления аппетита) и как диуретическое средство. В Республике Беларусь зарегистрированы лекарственные средства и биологически активные добавки к пище на его основе: одуванчика лекарственного корни измельченные (5600) по 100 г в пачке, одуванчика корни в пачках по 50 г и фильтр-пакетах 1,5 г и таблетки с витамином С 205 мг № 100 на основе одуванчика корней.

Об авторах

Р. И. Лукашов
Белорусский государственный медицинский университет
Беларусь


Н. С. Гурина
Белорусский государственный медицинский университет
Беларусь


Список литературы

1. Oduvanchika lekarstvennogo korni izmel’chennoe sir’e 100 g v pachke: instruktsiya po meditsinskomu primeneniyu [Dandelion roots crushed raw materials 100 g per pack: instruction on medical application] (elektronnii resurs). Available at: https://www.rceth.by/NDfiles/instr/18_06_438_s.pdf (accessed 02.12.2018).

2. Oduvanchik Farmgrupp [Dandelion Pharmgroup] (elektronnii resurs). Available at: https://apteka.ru/ catalog/oduvanchik-50-0-pak-_5950f6a1cba27 (accessed 02.12.2018).

3. Oduvanchik P [Dandelion P] (elektronnii resurs). Available at: https://www.piluli.ru/product/ oduvanchik_p (accessed 02.12.2018).

4. Community herbal monograph on Taraxacum officinale Weber ex Wigg., radix cum herba (elektronnii resurs). Available at: https://www.ema.europa.eu/documents/herbal-monograph/final-community-herbal- monograph-taraxacum-officinale-weber-ex-wigg-radix-cum-herba_en.pdf. (accessed 12.11.2018).

5. Assessment report on Taraxacum officinale Weber ex Wigg., radix cum herba (elektronnii resurs). Available at: https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-taraxacum-officinale- weber-ex-wigg-radix-cum-herba_en.pdf (accessed 12.11.2018).

6. Tabasum F. (2018) Dandelion: Phytochemistry and clinical potential. J. of Medicinal Plants Studies, vol. 6, no 2, pp. 198-202.

7. Newall C.A., Anderson L.A., Phillipson J.D. (1996) Herbal medicines. A guide for health-care professionals.

8. Pharm. Press, pp. 296-297.

9. Hook I. (1993) Evaluation of dandelion for diuretic activity and variation in potassium content. Int. J. Pharmaco, vol. 31, pp. 29-34.

10. Tita B. (1993) T. officinale W.: Pharmacological effect of ethanol extract. Pharnnacol. Res., vol. 27, pp. 23-24.

11. Hook I., McGee A., Henman M. (1993) Evaluation of dandelion for diuretic activity and variation in potassium content. Int. J. of Pharmacognosy, vol. 31, pp. 29-34.

12. Hussain Z. (2004) The effect of medicinal plants of Islamabad and Murree region of Pakistan on insulin secretion from INS-1 cells. Phytother. Res., vol. 18, no 1, pp. 73-77.

13. Tousch D. (2008) Chicoric acid, a new compound able to enhance insulin release and glucose uptake.

14. Biochem. Biophys. Res. Commun., vol. 377, no 1, pp. 131-145.

15. Schutz K., Carle R., Schieber A. (2006) Taraxacum - a review on its phytochemical and pharmacological profile. J. Ethnopharmacol., vol. 107, no 3, pp. 313-323.

16. Wirngo F.E., Lambert M.N., Jeppesen P.B. (2016) The Physiological Effects of Dandelion (Taraxacum officinale) in Type 2 Diabetes. The Review of diabetic studies, vol. 13, no 2-3, pp. 11-131.

17. Eddouks M. (2002) Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the South-east region of Morocco (Tafilalet).

18. J. Ethnopharmacol., vol. 82, no 2-3, pp. 97-103.

19. Prabhakar P.K., Doble M. (2008) A target based therapeutic approach towards diabetes mellitus using medicinal plants. Curr. Diabetes Rev., vol. 4, no 4, pp. 291-308.

20. Mukherjee P.K. (2006) Leads from Indian medicinal plants with hypoglycemic potentials.

21. J. Ethnopharmacol., vol. 106, no 1, pp. 1-28.

22. Bnouham M. (2006) Medicinal plants with potential antidiabetic activity - a review of ten years of herbal medicine research. Int. J. Diabetes Metab., vol. 14, no 1, pp. 1-25.

23. Jarald E., Joshi S.B., Jain D.C. (2008) Diabetes and herbal medicines. Iran J. Pharmacol. Ther., vol. 7, no 1, pp. 97-106.

24. Kumar S. (2011) Alpha-glucosidase inhibitors from plants: a natural approach to treat diabetes.

25. Pharmacogn. Rev., vol. 5, no 9, pp. 19-29.

26. Perk J. (2013) The fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. G. Ital. Cardiol., vol. 14, no 5, pp. 328-392.

27. Coman C., Rugina O.D., Socaciu C. (2012) Plants and natural compounds with antidiabetic action. Not. Bot. Horti Agrobo, vol. 40, no 1, pp. 314-325.

28. Vessal M., Hemmati M., Vasei M. (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. Part C. Toxicol. Pharmacol., vol. 135, no 3, pp. 357-364.

29. Prabhakar P., Doble M. (2008) A target-based therapeutic approach towards diabetes mellitus using medicinal plants. Curr. Diabetes Rev., vol. 4, no 4, pp. 291-308.

30. Bratanova-Tochkova T.K. (2002) Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes, vol. 51, no 1, pp. 83-90.

31. Seo S. (2005) Taraxacum officinale protects against cholecystokinin-induced acute pancreatitis in rats.

32. World J. Gastroenterol., vol. 11, no 4, pp. 597-599.

33. Koo H.N. (2004) Taraxacum officinale induces cytotoxicity through TNF-alpha and IL-1alpha secretion in Hep G2 cells. Life Sci., vol. 74, no 9, vol. 1149-1157.

34. Hong Y. (1997) The effect of Taraxacum mongolicum on immune function in mouse. J. of Guiyang Medical College, vol. 22, pp. 137-139.

35. Kim H.M. (2000) Taraxacum officinale inhibits tumor necrosis factor-alpha production from rat astrocytes.

36. Immunopharmacology and Immunotoxicology, vol. 22, pp. 519-530.

37. Kim H.M., Oh C.H., Chung C.K. (1999) Activation of inducible nitric oxide synthase by Taraxacum officinale in mouse peritoneal macrophages. Chung General Pharmacology, vol. 32, pp. 683-688.

38. Mascolo N. (1987) Biological screening of Italian medicinal plants for anti-inflammatory activity.

39. Phytotherapy Res., vol. 1, is. 1, pp. 28-29.

40. Kashiwada Y. (2001) Sesquiterpene Glucosides from Anti-leukotriene B4 Release Fraction of Taraxacum Officinale. J. of Asian Natural Products Research, vol. 3, no 3, pp. 191-197.

41. Huseini H.F. (2010) The Effects of Taraxacum officinale L. and Berberis vulgaris L. Root Extracts on Carbon Tetrachloride Induced Liver Toxicity in Rats. J. of Medicinal Plants, vol. 9, pp. 45-52.

42. Sweeney B. (2005) Evidence-based systematic review of dandelion (Taraxacum officinale) by natural standard research collaboration. J. Herb. Pharmacother., vol. 5, pp. 79-93.

43. Bohm K. (1959) Untersuchungen uber choleretische Wirkungen einiger Arzneipfl anzen.

44. Arzneimittelforschung, vol. 9, pp. 376-378.

45. Modaresi M., Resalatpour N. (2012) The Effect of Taraxacum officinale Hydroalcoholic Extract on Blood Cells in Mice. Advances in Hematology, vol. 2012, pp. 1-4.

46. Tsai H.-H. (2013) A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines. Drug Interactions of Chinese Herbal Medicines, vol. 8, is. 5, pp. 1-11.

47. Kim J. (2007) Antioxidative, antiinflammatory and antiatherogenic effects of dandelion (Taraxacum officinale) extracts in C57BL/6 mice fed atherogenic diet. The FASEB J., vol. 21, pp. 862-867.

48. Trojanova I. (2004) The bifidogenic effect of Taraxacum officinale root. Fitoterapia, vol. 75, no 7-8, pp. 760-763.

49. Gerbino A. (2018) Dandelion Root Extract Induces Intracellular Ca2+ Increases in HEK293 Cells. Int. J. Mol. Sci., vol. 19, pp. 1112-1119.

50. Akhtar M.S., Khan Q.M., Khaliq T. (1985) Effects of Portulaca oleracae (Kulfa) and Taraxacum officinale (Dhudhal) in normoglycaemic and alloxan-treated hyperglycaemic rabbits. J. Pak. Med. Assoc., vol. 35, no 7, pp. 207-210.

51. Racz-Kotilla E., Racz G., Solomon A. (1974) Action of Taraxacum officinale extracts on body-weight and diuresis of laboratory-animals. Planta Med., vol. 26, pp. 262-217.

52. Leslie G.B., Salmon G. (1979) Repeated dose toxicity studies and reproductive studies on nine Bio-Strath herbal remedies. Schweizerische Zeitschrift fur Medizin und Medizinische Technik, vol. 1, pp. 1-3.

53. Lovell C.R., Rowan M. (1991) Dandelion dermatitis. Contact Dermatitis, vol. 25, no 3, pp. 185-188.

54. Hu C., Kitts D.D. (2003) Antioxidant, prooxidant and cytotoxic activities of solvent-fractionated Dandelion (Taraxacum officinale) flower extracts in vitro. J. Agric. Food Chem., vol. 51, no 1, pp. 301-310.

55. Hu C., Kitts D.D. (2005) Dandelion (Taraxacum officinale) flower extract suppresses both reactive oxygen species and nitric oxide and prevents lipid oxidation in vitro. Phytomedicine, vol. 12, no 8, pp. 588-597.


Для цитирования:


Лукашов Р.И., Гурина Н.С. Одуванчик лекарственный. Часть 2. Фармакологические свойства. Рецепт. 2019;(2):259-265.

For citation:


Lukashou R..., Gurina N... Dandelion. Part 2. Pharmacological Properties. Recipe. 2019;(2):259-265. (In Russ.)

Просмотров: 18


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1993-4882 (Print)
ISSN 2414-2263 (Online)